Orphan Drug - MM&M - Medical Marketing and Media

Orphan Drug

Five things for pharma marketers to know: Wednesday, November 5

Five things for pharma marketers to know: Wednesday, November 5

The Hill outlines its healthcare expectations with a GOP Congress, Sanofi’s executive shakeup may have an impact on MannKind’s Afrezza launch, AstraZeneca’s olaparib may have prostate cancer prospects, the FDA granted orphan status to an experimental Merrimack pancreatic cancer drug, and researchers are struggling to get Ebola virus samples.